Catechins can modulate the secretion of urokinase plasminogen activator (uPA), which is closely related to proteolytic enzymes in breast cancer cells and inhibits their invasive behavior by suppressing the transcription factors AP-1 and NF-κB [71]. Here, PLAU is linked to breast carcinoma.